ANI Pharmaceuticals
ANIP
ANIP
205 hedge funds and large institutions have $1.07B invested in ANI Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 69 increasing their positions, 60 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
6% less capital invested
Capital invested by funds: $1.14B → $1.07B (-$71.7M)
69% less call options, than puts
Call options by funds: $188K | Put options by funds: $597K
Holders
205
Holding in Top 10
–
Calls
$188K
Puts
$597K
Top Buyers
| 1 | +$27.2M | |
| 2 | +$17.7M | |
| 3 | +$13.7M | |
| 4 |
SCM
Sio Capital Management
New York
|
+$9.19M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$8.28M |
Top Sellers
| 1 | -$32.5M | |
| 2 | -$16.5M | |
| 3 | -$10M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$9.34M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
-$7.61M |